Global Oral Obesity Therapies Market Growth (Status and Outlook) 2026-2032
The global Oral Obesity Therapies market size is predicted to grow from US$ 4227 million in 2025 to US$ 7266 million in 2032; it is expected to grow at a CAGR of 8.0% from 2026 to 2032.
Oral Obesity Therapies refer to systemic pharmacological treatments administered orally to manage body weight and improve metabolic health. These therapies include small-molecule drugs, incretin modulators, appetite suppressants, and metabolic regulators designed to influence central appetite signaling, delay gastric emptying, enhance fat oxidation, or reduce nutrient absorption. Compared with injectable GLP-1 therapies, oral formulations offer improved patient compliance, convenience, and broader acceptance. As obesity is increasingly recognized as a chronic disease requiring long-term management, oral obesity therapies are evolving from short-term weight-loss solutions into comprehensive metabolic intervention strategies.The average gross profit margin of this product is 60%.
The rising global prevalence of obesity and related chronic diseases is the primary growth driver for oral obesity therapies. Increasing public health awareness and expanded reimbursement coverage are integrating long-term weight management into formal treatment pathways. Breakthroughs in GLP-1 receptor agonists, oral small-molecule alternatives, and multi-target combination therapies have significantly improved efficacy and safety profiles. Strong capital market interest in metabolic disease innovation is accelerating drug development. The expansion of digital health platforms and telemedicine further enhances patient access to oral treatment options.
Key challenges include stringent regulatory scrutiny on safety, the need for long-term efficacy data, and management of potential adverse effects. Some therapies may carry cardiovascular or psychiatric risks, increasing clinical and post-marketing surveillance costs. Patent competition and generic entry may pressure margins. High patient expectations for weight reduction outcomes can impact market reputation if results fall short. Pricing structures and reimbursement policies also influence market penetration rates.
Demand trends reflect a shift toward chronic disease management and younger patient demographics. The obese population increasingly includes working-age adults seeking convenient and safe long-term oral solutions. Female consumers and individuals at high risk of metabolic syndrome represent major growth segments. Physician-driven prescriptions are strengthening, transforming weight loss from aesthetic motivation to medical management. Consumers prioritize clinical validation and scientific endorsement. Online medical consultation and pharmaceutical delivery models are further expanding market reach.
Upstream components include active pharmaceutical ingredients, small-molecule intermediates, incretin analog precursors, excipients, and controlled-release carrier systems. Advanced chemical synthesis and biotechnological platforms form the technical foundation. Core ingredients often rely on specialized API manufacturers with high technical barriers. Formulation development emphasizes stability and bioavailability enhancement, with controlled-release and enteric coating technologies playing critical roles. Sustainable manufacturing processes and quality traceability systems are emerging as competitive differentiators within the supply chain.
LPI (LP Information)' newest research report, the “Oral Obesity Therapies Industry Forecast” looks at past sales and reviews total world Oral Obesity Therapies sales in 2025, providing a comprehensive analysis by region and market sector of projected Oral Obesity Therapies sales for 2026 through 2032. With Oral Obesity Therapies sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oral Obesity Therapies industry.
This Insight Report provides a comprehensive analysis of the global Oral Obesity Therapies landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Oral Obesity Therapies portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oral Obesity Therapies market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oral Obesity Therapies and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oral Obesity Therapies.
This report presents a comprehensive overview, market shares, and growth opportunities of Oral Obesity Therapies market by product type, application, key players and key regions and countries.
Segmentation by Type:
Oral Obesity Therapies refer to systemic pharmacological treatments administered orally to manage body weight and improve metabolic health. These therapies include small-molecule drugs, incretin modulators, appetite suppressants, and metabolic regulators designed to influence central appetite signaling, delay gastric emptying, enhance fat oxidation, or reduce nutrient absorption. Compared with injectable GLP-1 therapies, oral formulations offer improved patient compliance, convenience, and broader acceptance. As obesity is increasingly recognized as a chronic disease requiring long-term management, oral obesity therapies are evolving from short-term weight-loss solutions into comprehensive metabolic intervention strategies.The average gross profit margin of this product is 60%.
The rising global prevalence of obesity and related chronic diseases is the primary growth driver for oral obesity therapies. Increasing public health awareness and expanded reimbursement coverage are integrating long-term weight management into formal treatment pathways. Breakthroughs in GLP-1 receptor agonists, oral small-molecule alternatives, and multi-target combination therapies have significantly improved efficacy and safety profiles. Strong capital market interest in metabolic disease innovation is accelerating drug development. The expansion of digital health platforms and telemedicine further enhances patient access to oral treatment options.
Key challenges include stringent regulatory scrutiny on safety, the need for long-term efficacy data, and management of potential adverse effects. Some therapies may carry cardiovascular or psychiatric risks, increasing clinical and post-marketing surveillance costs. Patent competition and generic entry may pressure margins. High patient expectations for weight reduction outcomes can impact market reputation if results fall short. Pricing structures and reimbursement policies also influence market penetration rates.
Demand trends reflect a shift toward chronic disease management and younger patient demographics. The obese population increasingly includes working-age adults seeking convenient and safe long-term oral solutions. Female consumers and individuals at high risk of metabolic syndrome represent major growth segments. Physician-driven prescriptions are strengthening, transforming weight loss from aesthetic motivation to medical management. Consumers prioritize clinical validation and scientific endorsement. Online medical consultation and pharmaceutical delivery models are further expanding market reach.
Upstream components include active pharmaceutical ingredients, small-molecule intermediates, incretin analog precursors, excipients, and controlled-release carrier systems. Advanced chemical synthesis and biotechnological platforms form the technical foundation. Core ingredients often rely on specialized API manufacturers with high technical barriers. Formulation development emphasizes stability and bioavailability enhancement, with controlled-release and enteric coating technologies playing critical roles. Sustainable manufacturing processes and quality traceability systems are emerging as competitive differentiators within the supply chain.
LPI (LP Information)' newest research report, the “Oral Obesity Therapies Industry Forecast” looks at past sales and reviews total world Oral Obesity Therapies sales in 2025, providing a comprehensive analysis by region and market sector of projected Oral Obesity Therapies sales for 2026 through 2032. With Oral Obesity Therapies sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oral Obesity Therapies industry.
This Insight Report provides a comprehensive analysis of the global Oral Obesity Therapies landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Oral Obesity Therapies portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oral Obesity Therapies market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oral Obesity Therapies and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oral Obesity Therapies.
This report presents a comprehensive overview, market shares, and growth opportunities of Oral Obesity Therapies market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Lipase Inhibitors
- Sympathomimetic Appetite Suppressants
- Oral GLP-1 Agonists
- Other
- Small Molecules
- Peptide Oral
- Combination Drugs
- Other
- BMI ?30 Primary Obesity
- Overweight + Metabolic Comorbidities
- Short-term Weight Reduction
- Weight Maintenance
- Hospitals
- Retail Pharmacies
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Currax Pharmaceuticals, LLC
- Vivus, Inc.
- Roche Holding AG
- Teva Pharmaceutical Industries Ltd.
- Sun Pharmaceutical Industries Ltd.
- Novo Nordisk A/S
- Pfizer Inc.
- Arena Pharmaceuticals, Inc.
- Rhythm Pharmaceuticals, Inc.
- Gelesis
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oral Obesity Therapies Market Size (2021-2032)
2.1.2 Oral Obesity Therapies Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Oral Obesity Therapies by Country/Region (2021, 2025 & 2032)
2.2 Oral Obesity Therapies Segment by Type
2.2.1 Lipase Inhibitors
2.2.2 Sympathomimetic Appetite Suppressants
2.2.3 Oral GLP-1 Agonists
2.2.4 Other
2.2.5 Oral Obesity Therapies Market Size by Type
2.2.5.1 Oral Obesity Therapies Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Oral Obesity Therapies Market Size Market Share by Type (2021-2026)
2.3 Oral Obesity Therapies Segment by Drug Type
2.3.1 Small Molecules
2.3.2 Peptide Oral
2.3.3 Combination Drugs
2.3.4 Other
2.3.5 Oral Obesity Therapies Market Size by Drug Type
2.3.5.1 Oral Obesity Therapies Market Size CAGR by Drug Type (2021 VS 2025 VS 2032)
2.3.5.2 Global Oral Obesity Therapies Market Size Market Share by Drug Type (2021-2026)
2.4 Oral Obesity Therapies Segment by Patient Indication
2.4.1 BMI ?30 Primary Obesity
2.4.2 Overweight + Metabolic Comorbidities
2.4.3 Short-term Weight Reduction
2.4.4 Weight Maintenance
2.4.5 Oral Obesity Therapies Market Size by Patient Indication
2.4.5.1 Oral Obesity Therapies Market Size CAGR by Patient Indication (2021 VS 2025 VS 2032)
2.4.5.2 Global Oral Obesity Therapies Market Size Market Share by Patient Indication (2021-2026)
2.5 Oral Obesity Therapies Segment by Application
2.5.1 Hospitals
2.5.2 Retail Pharmacies
2.5.3 Other
2.5.4 Oral Obesity Therapies Market Size by Application
2.5.4.1 Oral Obesity Therapies Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.4.2 Global Oral Obesity Therapies Market Size Market Share by Application (2021-2026)
3 ORAL OBESITY THERAPIES MARKET SIZE BY PLAYER
3.1 Oral Obesity Therapies Market Size Market Share by Player
3.1.1 Global Oral Obesity Therapies Revenue by Player (2021-2026)
3.1.2 Global Oral Obesity Therapies Revenue Market Share by Player (2021-2026)
3.2 Global Oral Obesity Therapies Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ORAL OBESITY THERAPIES BY REGION
4.1 Oral Obesity Therapies Market Size by Region (2021-2026)
4.2 Global Oral Obesity Therapies Annual Revenue by Country/Region (2021-2026)
4.3 Americas Oral Obesity Therapies Market Size Growth (2021-2026)
4.4 APAC Oral Obesity Therapies Market Size Growth (2021-2026)
4.5 Europe Oral Obesity Therapies Market Size Growth (2021-2026)
4.6 Middle East & Africa Oral Obesity Therapies Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Oral Obesity Therapies Market Size by Country (2021-2026)
5.2 Americas Oral Obesity Therapies Market Size by Type (2021-2026)
5.3 Americas Oral Obesity Therapies Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oral Obesity Therapies Market Size by Region (2021-2026)
6.2 APAC Oral Obesity Therapies Market Size by Type (2021-2026)
6.3 APAC Oral Obesity Therapies Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Oral Obesity Therapies Market Size by Country (2021-2026)
7.2 Europe Oral Obesity Therapies Market Size by Type (2021-2026)
7.3 Europe Oral Obesity Therapies Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oral Obesity Therapies by Region (2021-2026)
8.2 Middle East & Africa Oral Obesity Therapies Market Size by Type (2021-2026)
8.3 Middle East & Africa Oral Obesity Therapies Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ORAL OBESITY THERAPIES MARKET FORECAST
10.1 Global Oral Obesity Therapies Forecast by Region (2027-2032)
10.1.1 Global Oral Obesity Therapies Forecast by Region (2027-2032)
10.1.2 Americas Oral Obesity Therapies Forecast
10.1.3 APAC Oral Obesity Therapies Forecast
10.1.4 Europe Oral Obesity Therapies Forecast
10.1.5 Middle East & Africa Oral Obesity Therapies Forecast
10.2 Americas Oral Obesity Therapies Forecast by Country (2027-2032)
10.2.1 United States Market Oral Obesity Therapies Forecast
10.2.2 Canada Market Oral Obesity Therapies Forecast
10.2.3 Mexico Market Oral Obesity Therapies Forecast
10.2.4 Brazil Market Oral Obesity Therapies Forecast
10.3 APAC Oral Obesity Therapies Forecast by Region (2027-2032)
10.3.1 China Oral Obesity Therapies Market Forecast
10.3.2 Japan Market Oral Obesity Therapies Forecast
10.3.3 Korea Market Oral Obesity Therapies Forecast
10.3.4 Southeast Asia Market Oral Obesity Therapies Forecast
10.3.5 India Market Oral Obesity Therapies Forecast
10.3.6 Australia Market Oral Obesity Therapies Forecast
10.4 Europe Oral Obesity Therapies Forecast by Country (2027-2032)
10.4.1 Germany Market Oral Obesity Therapies Forecast
10.4.2 France Market Oral Obesity Therapies Forecast
10.4.3 UK Market Oral Obesity Therapies Forecast
10.4.4 Italy Market Oral Obesity Therapies Forecast
10.4.5 Russia Market Oral Obesity Therapies Forecast
10.5 Middle East & Africa Oral Obesity Therapies Forecast by Region (2027-2032)
10.5.1 Egypt Market Oral Obesity Therapies Forecast
10.5.2 South Africa Market Oral Obesity Therapies Forecast
10.5.3 Israel Market Oral Obesity Therapies Forecast
10.5.4 Turkey Market Oral Obesity Therapies Forecast
10.6 Global Oral Obesity Therapies Forecast by Type (2027-2032)
10.7 Global Oral Obesity Therapies Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Oral Obesity Therapies Forecast
11 KEY PLAYERS ANALYSIS
11.1 Currax Pharmaceuticals, LLC
11.1.1 Currax Pharmaceuticals, LLC Company Information
11.1.2 Currax Pharmaceuticals, LLC Oral Obesity Therapies Product Offered
11.1.3 Currax Pharmaceuticals, LLC Oral Obesity Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Currax Pharmaceuticals, LLC Main Business Overview
11.1.5 Currax Pharmaceuticals, LLC Latest Developments
11.2 Vivus, Inc.
11.2.1 Vivus, Inc. Company Information
11.2.2 Vivus, Inc. Oral Obesity Therapies Product Offered
11.2.3 Vivus, Inc. Oral Obesity Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Vivus, Inc. Main Business Overview
11.2.5 Vivus, Inc. Latest Developments
11.3 Roche Holding AG
11.3.1 Roche Holding AG Company Information
11.3.2 Roche Holding AG Oral Obesity Therapies Product Offered
11.3.3 Roche Holding AG Oral Obesity Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Roche Holding AG Main Business Overview
11.3.5 Roche Holding AG Latest Developments
11.4 Teva Pharmaceutical Industries Ltd.
11.4.1 Teva Pharmaceutical Industries Ltd. Company Information
11.4.2 Teva Pharmaceutical Industries Ltd. Oral Obesity Therapies Product Offered
11.4.3 Teva Pharmaceutical Industries Ltd. Oral Obesity Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Teva Pharmaceutical Industries Ltd. Main Business Overview
11.4.5 Teva Pharmaceutical Industries Ltd. Latest Developments
11.5 Sun Pharmaceutical Industries Ltd.
11.5.1 Sun Pharmaceutical Industries Ltd. Company Information
11.5.2 Sun Pharmaceutical Industries Ltd. Oral Obesity Therapies Product Offered
11.5.3 Sun Pharmaceutical Industries Ltd. Oral Obesity Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Sun Pharmaceutical Industries Ltd. Main Business Overview
11.5.5 Sun Pharmaceutical Industries Ltd. Latest Developments
11.6 Novo Nordisk A/S
11.6.1 Novo Nordisk A/S Company Information
11.6.2 Novo Nordisk A/S Oral Obesity Therapies Product Offered
11.6.3 Novo Nordisk A/S Oral Obesity Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Novo Nordisk A/S Main Business Overview
11.6.5 Novo Nordisk A/S Latest Developments
11.7 Pfizer Inc.
11.7.1 Pfizer Inc. Company Information
11.7.2 Pfizer Inc. Oral Obesity Therapies Product Offered
11.7.3 Pfizer Inc. Oral Obesity Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Pfizer Inc. Main Business Overview
11.7.5 Pfizer Inc. Latest Developments
11.8 Arena Pharmaceuticals, Inc.
11.8.1 Arena Pharmaceuticals, Inc. Company Information
11.8.2 Arena Pharmaceuticals, Inc. Oral Obesity Therapies Product Offered
11.8.3 Arena Pharmaceuticals, Inc. Oral Obesity Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Arena Pharmaceuticals, Inc. Main Business Overview
11.8.5 Arena Pharmaceuticals, Inc. Latest Developments
11.9 Rhythm Pharmaceuticals, Inc.
11.9.1 Rhythm Pharmaceuticals, Inc. Company Information
11.9.2 Rhythm Pharmaceuticals, Inc. Oral Obesity Therapies Product Offered
11.9.3 Rhythm Pharmaceuticals, Inc. Oral Obesity Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Rhythm Pharmaceuticals, Inc. Main Business Overview
11.9.5 Rhythm Pharmaceuticals, Inc. Latest Developments
11.10 Gelesis
11.10.1 Gelesis Company Information
11.10.2 Gelesis Oral Obesity Therapies Product Offered
11.10.3 Gelesis Oral Obesity Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Gelesis Main Business Overview
11.10.5 Gelesis Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oral Obesity Therapies Market Size (2021-2032)
2.1.2 Oral Obesity Therapies Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Oral Obesity Therapies by Country/Region (2021, 2025 & 2032)
2.2 Oral Obesity Therapies Segment by Type
2.2.1 Lipase Inhibitors
2.2.2 Sympathomimetic Appetite Suppressants
2.2.3 Oral GLP-1 Agonists
2.2.4 Other
2.2.5 Oral Obesity Therapies Market Size by Type
2.2.5.1 Oral Obesity Therapies Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Oral Obesity Therapies Market Size Market Share by Type (2021-2026)
2.3 Oral Obesity Therapies Segment by Drug Type
2.3.1 Small Molecules
2.3.2 Peptide Oral
2.3.3 Combination Drugs
2.3.4 Other
2.3.5 Oral Obesity Therapies Market Size by Drug Type
2.3.5.1 Oral Obesity Therapies Market Size CAGR by Drug Type (2021 VS 2025 VS 2032)
2.3.5.2 Global Oral Obesity Therapies Market Size Market Share by Drug Type (2021-2026)
2.4 Oral Obesity Therapies Segment by Patient Indication
2.4.1 BMI ?30 Primary Obesity
2.4.2 Overweight + Metabolic Comorbidities
2.4.3 Short-term Weight Reduction
2.4.4 Weight Maintenance
2.4.5 Oral Obesity Therapies Market Size by Patient Indication
2.4.5.1 Oral Obesity Therapies Market Size CAGR by Patient Indication (2021 VS 2025 VS 2032)
2.4.5.2 Global Oral Obesity Therapies Market Size Market Share by Patient Indication (2021-2026)
2.5 Oral Obesity Therapies Segment by Application
2.5.1 Hospitals
2.5.2 Retail Pharmacies
2.5.3 Other
2.5.4 Oral Obesity Therapies Market Size by Application
2.5.4.1 Oral Obesity Therapies Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.4.2 Global Oral Obesity Therapies Market Size Market Share by Application (2021-2026)
3 ORAL OBESITY THERAPIES MARKET SIZE BY PLAYER
3.1 Oral Obesity Therapies Market Size Market Share by Player
3.1.1 Global Oral Obesity Therapies Revenue by Player (2021-2026)
3.1.2 Global Oral Obesity Therapies Revenue Market Share by Player (2021-2026)
3.2 Global Oral Obesity Therapies Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ORAL OBESITY THERAPIES BY REGION
4.1 Oral Obesity Therapies Market Size by Region (2021-2026)
4.2 Global Oral Obesity Therapies Annual Revenue by Country/Region (2021-2026)
4.3 Americas Oral Obesity Therapies Market Size Growth (2021-2026)
4.4 APAC Oral Obesity Therapies Market Size Growth (2021-2026)
4.5 Europe Oral Obesity Therapies Market Size Growth (2021-2026)
4.6 Middle East & Africa Oral Obesity Therapies Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Oral Obesity Therapies Market Size by Country (2021-2026)
5.2 Americas Oral Obesity Therapies Market Size by Type (2021-2026)
5.3 Americas Oral Obesity Therapies Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oral Obesity Therapies Market Size by Region (2021-2026)
6.2 APAC Oral Obesity Therapies Market Size by Type (2021-2026)
6.3 APAC Oral Obesity Therapies Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Oral Obesity Therapies Market Size by Country (2021-2026)
7.2 Europe Oral Obesity Therapies Market Size by Type (2021-2026)
7.3 Europe Oral Obesity Therapies Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oral Obesity Therapies by Region (2021-2026)
8.2 Middle East & Africa Oral Obesity Therapies Market Size by Type (2021-2026)
8.3 Middle East & Africa Oral Obesity Therapies Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ORAL OBESITY THERAPIES MARKET FORECAST
10.1 Global Oral Obesity Therapies Forecast by Region (2027-2032)
10.1.1 Global Oral Obesity Therapies Forecast by Region (2027-2032)
10.1.2 Americas Oral Obesity Therapies Forecast
10.1.3 APAC Oral Obesity Therapies Forecast
10.1.4 Europe Oral Obesity Therapies Forecast
10.1.5 Middle East & Africa Oral Obesity Therapies Forecast
10.2 Americas Oral Obesity Therapies Forecast by Country (2027-2032)
10.2.1 United States Market Oral Obesity Therapies Forecast
10.2.2 Canada Market Oral Obesity Therapies Forecast
10.2.3 Mexico Market Oral Obesity Therapies Forecast
10.2.4 Brazil Market Oral Obesity Therapies Forecast
10.3 APAC Oral Obesity Therapies Forecast by Region (2027-2032)
10.3.1 China Oral Obesity Therapies Market Forecast
10.3.2 Japan Market Oral Obesity Therapies Forecast
10.3.3 Korea Market Oral Obesity Therapies Forecast
10.3.4 Southeast Asia Market Oral Obesity Therapies Forecast
10.3.5 India Market Oral Obesity Therapies Forecast
10.3.6 Australia Market Oral Obesity Therapies Forecast
10.4 Europe Oral Obesity Therapies Forecast by Country (2027-2032)
10.4.1 Germany Market Oral Obesity Therapies Forecast
10.4.2 France Market Oral Obesity Therapies Forecast
10.4.3 UK Market Oral Obesity Therapies Forecast
10.4.4 Italy Market Oral Obesity Therapies Forecast
10.4.5 Russia Market Oral Obesity Therapies Forecast
10.5 Middle East & Africa Oral Obesity Therapies Forecast by Region (2027-2032)
10.5.1 Egypt Market Oral Obesity Therapies Forecast
10.5.2 South Africa Market Oral Obesity Therapies Forecast
10.5.3 Israel Market Oral Obesity Therapies Forecast
10.5.4 Turkey Market Oral Obesity Therapies Forecast
10.6 Global Oral Obesity Therapies Forecast by Type (2027-2032)
10.7 Global Oral Obesity Therapies Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Oral Obesity Therapies Forecast
11 KEY PLAYERS ANALYSIS
11.1 Currax Pharmaceuticals, LLC
11.1.1 Currax Pharmaceuticals, LLC Company Information
11.1.2 Currax Pharmaceuticals, LLC Oral Obesity Therapies Product Offered
11.1.3 Currax Pharmaceuticals, LLC Oral Obesity Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Currax Pharmaceuticals, LLC Main Business Overview
11.1.5 Currax Pharmaceuticals, LLC Latest Developments
11.2 Vivus, Inc.
11.2.1 Vivus, Inc. Company Information
11.2.2 Vivus, Inc. Oral Obesity Therapies Product Offered
11.2.3 Vivus, Inc. Oral Obesity Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Vivus, Inc. Main Business Overview
11.2.5 Vivus, Inc. Latest Developments
11.3 Roche Holding AG
11.3.1 Roche Holding AG Company Information
11.3.2 Roche Holding AG Oral Obesity Therapies Product Offered
11.3.3 Roche Holding AG Oral Obesity Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Roche Holding AG Main Business Overview
11.3.5 Roche Holding AG Latest Developments
11.4 Teva Pharmaceutical Industries Ltd.
11.4.1 Teva Pharmaceutical Industries Ltd. Company Information
11.4.2 Teva Pharmaceutical Industries Ltd. Oral Obesity Therapies Product Offered
11.4.3 Teva Pharmaceutical Industries Ltd. Oral Obesity Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Teva Pharmaceutical Industries Ltd. Main Business Overview
11.4.5 Teva Pharmaceutical Industries Ltd. Latest Developments
11.5 Sun Pharmaceutical Industries Ltd.
11.5.1 Sun Pharmaceutical Industries Ltd. Company Information
11.5.2 Sun Pharmaceutical Industries Ltd. Oral Obesity Therapies Product Offered
11.5.3 Sun Pharmaceutical Industries Ltd. Oral Obesity Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Sun Pharmaceutical Industries Ltd. Main Business Overview
11.5.5 Sun Pharmaceutical Industries Ltd. Latest Developments
11.6 Novo Nordisk A/S
11.6.1 Novo Nordisk A/S Company Information
11.6.2 Novo Nordisk A/S Oral Obesity Therapies Product Offered
11.6.3 Novo Nordisk A/S Oral Obesity Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Novo Nordisk A/S Main Business Overview
11.6.5 Novo Nordisk A/S Latest Developments
11.7 Pfizer Inc.
11.7.1 Pfizer Inc. Company Information
11.7.2 Pfizer Inc. Oral Obesity Therapies Product Offered
11.7.3 Pfizer Inc. Oral Obesity Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Pfizer Inc. Main Business Overview
11.7.5 Pfizer Inc. Latest Developments
11.8 Arena Pharmaceuticals, Inc.
11.8.1 Arena Pharmaceuticals, Inc. Company Information
11.8.2 Arena Pharmaceuticals, Inc. Oral Obesity Therapies Product Offered
11.8.3 Arena Pharmaceuticals, Inc. Oral Obesity Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Arena Pharmaceuticals, Inc. Main Business Overview
11.8.5 Arena Pharmaceuticals, Inc. Latest Developments
11.9 Rhythm Pharmaceuticals, Inc.
11.9.1 Rhythm Pharmaceuticals, Inc. Company Information
11.9.2 Rhythm Pharmaceuticals, Inc. Oral Obesity Therapies Product Offered
11.9.3 Rhythm Pharmaceuticals, Inc. Oral Obesity Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Rhythm Pharmaceuticals, Inc. Main Business Overview
11.9.5 Rhythm Pharmaceuticals, Inc. Latest Developments
11.10 Gelesis
11.10.1 Gelesis Company Information
11.10.2 Gelesis Oral Obesity Therapies Product Offered
11.10.3 Gelesis Oral Obesity Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Gelesis Main Business Overview
11.10.5 Gelesis Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Oral Obesity Therapies Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Oral Obesity Therapies Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Lipase Inhibitors
Table 4. Major Players of Sympathomimetic Appetite Suppressants
Table 5. Major Players of Oral GLP-1 Agonists
Table 6. Major Players of Other
Table 7. Oral Obesity Therapies Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Oral Obesity Therapies Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Oral Obesity Therapies Market Size Market Share by Type (2021-2026)
Table 10. Major Players of Small Molecules
Table 11. Major Players of Peptide Oral
Table 12. Major Players of Combination Drugs
Table 13. Major Players of Other
Table 14. Oral Obesity Therapies Market Size CAGR by Drug Type (2021 VS 2025 VS 2032) & ($ millions)
Table 15. Global Oral Obesity Therapies Market Size by Drug Type (2021-2026) & ($ millions)
Table 16. Global Oral Obesity Therapies Market Size Market Share by Drug Type (2021-2026)
Table 17. Major Players of BMI ?30 Primary Obesity
Table 18. Major Players of Overweight + Metabolic Comorbidities
Table 19. Major Players of Short-term Weight Reduction
Table 20. Major Players of Weight Maintenance
Table 21. Oral Obesity Therapies Market Size CAGR by Patient Indication (2021 VS 2025 VS 2032) & ($ millions)
Table 22. Global Oral Obesity Therapies Market Size by Patient Indication (2021-2026) & ($ millions)
Table 23. Global Oral Obesity Therapies Market Size Market Share by Patient Indication (2021-2026)
Table 24. Oral Obesity Therapies Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 25. Global Oral Obesity Therapies Market Size by Application (2021-2026) & ($ millions)
Table 26. Global Oral Obesity Therapies Market Size Market Share by Application (2021-2026)
Table 27. Global Oral Obesity Therapies Revenue by Player (2021-2026) & ($ millions)
Table 28. Global Oral Obesity Therapies Revenue Market Share by Player (2021-2026)
Table 29. Oral Obesity Therapies Key Players Head office and Products Offered
Table 30. Oral Obesity Therapies Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 31. New Products and Potential Entrants
Table 32. Mergers & Acquisitions, Expansion
Table 33. Global Oral Obesity Therapies Market Size by Region (2021-2026) & ($ millions)
Table 34. Global Oral Obesity Therapies Market Size Market Share by Region (2021-2026)
Table 35. Global Oral Obesity Therapies Revenue by Country/Region (2021-2026) & ($ millions)
Table 36. Global Oral Obesity Therapies Revenue Market Share by Country/Region (2021-2026)
Table 37. Americas Oral Obesity Therapies Market Size by Country (2021-2026) & ($ millions)
Table 38. Americas Oral Obesity Therapies Market Size Market Share by Country (2021-2026)
Table 39. Americas Oral Obesity Therapies Market Size by Type (2021-2026) & ($ millions)
Table 40. Americas Oral Obesity Therapies Market Size Market Share by Type (2021-2026)
Table 41. Americas Oral Obesity Therapies Market Size by Application (2021-2026) & ($ millions)
Table 42. Americas Oral Obesity Therapies Market Size Market Share by Application (2021-2026)
Table 43. APAC Oral Obesity Therapies Market Size by Region (2021-2026) & ($ millions)
Table 44. APAC Oral Obesity Therapies Market Size Market Share by Region (2021-2026)
Table 45. APAC Oral Obesity Therapies Market Size by Type (2021-2026) & ($ millions)
Table 46. APAC Oral Obesity Therapies Market Size by Application (2021-2026) & ($ millions)
Table 47. Europe Oral Obesity Therapies Market Size by Country (2021-2026) & ($ millions)
Table 48. Europe Oral Obesity Therapies Market Size Market Share by Country (2021-2026)
Table 49. Europe Oral Obesity Therapies Market Size by Type (2021-2026) & ($ millions)
Table 50. Europe Oral Obesity Therapies Market Size by Application (2021-2026) & ($ millions)
Table 51. Middle East & Africa Oral Obesity Therapies Market Size by Region (2021-2026) & ($ millions)
Table 52. Middle East & Africa Oral Obesity Therapies Market Size by Type (2021-2026) & ($ millions)
Table 53. Middle East & Africa Oral Obesity Therapies Market Size by Application (2021-2026) & ($ millions)
Table 54. Key Market Drivers & Growth Opportunities of Oral Obesity Therapies
Table 55. Key Market Challenges & Risks of Oral Obesity Therapies
Table 56. Key Industry Trends of Oral Obesity Therapies
Table 57. Global Oral Obesity Therapies Market Size Forecast by Region (2027-2032) & ($ millions)
Table 58. Global Oral Obesity Therapies Market Size Market Share Forecast by Region (2027-2032)
Table 59. Global Oral Obesity Therapies Market Size Forecast by Type (2027-2032) & ($ millions)
Table 60. Global Oral Obesity Therapies Market Size Forecast by Application (2027-2032) & ($ millions)
Table 61. Currax Pharmaceuticals, LLC Details, Company Type, Oral Obesity Therapies Area Served and Its Competitors
Table 62. Currax Pharmaceuticals, LLC Oral Obesity Therapies Product Offered
Table 63. Currax Pharmaceuticals, LLC Oral Obesity Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Currax Pharmaceuticals, LLC Main Business
Table 65. Currax Pharmaceuticals, LLC Latest Developments
Table 66. Vivus, Inc. Details, Company Type, Oral Obesity Therapies Area Served and Its Competitors
Table 67. Vivus, Inc. Oral Obesity Therapies Product Offered
Table 68. Vivus, Inc. Oral Obesity Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Vivus, Inc. Main Business
Table 70. Vivus, Inc. Latest Developments
Table 71. Roche Holding AG Details, Company Type, Oral Obesity Therapies Area Served and Its Competitors
Table 72. Roche Holding AG Oral Obesity Therapies Product Offered
Table 73. Roche Holding AG Oral Obesity Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Roche Holding AG Main Business
Table 75. Roche Holding AG Latest Developments
Table 76. Teva Pharmaceutical Industries Ltd. Details, Company Type, Oral Obesity Therapies Area Served and Its Competitors
Table 77. Teva Pharmaceutical Industries Ltd. Oral Obesity Therapies Product Offered
Table 78. Teva Pharmaceutical Industries Ltd. Oral Obesity Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Teva Pharmaceutical Industries Ltd. Main Business
Table 80. Teva Pharmaceutical Industries Ltd. Latest Developments
Table 81. Sun Pharmaceutical Industries Ltd. Details, Company Type, Oral Obesity Therapies Area Served and Its Competitors
Table 82. Sun Pharmaceutical Industries Ltd. Oral Obesity Therapies Product Offered
Table 83. Sun Pharmaceutical Industries Ltd. Oral Obesity Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Sun Pharmaceutical Industries Ltd. Main Business
Table 85. Sun Pharmaceutical Industries Ltd. Latest Developments
Table 86. Novo Nordisk A/S Details, Company Type, Oral Obesity Therapies Area Served and Its Competitors
Table 87. Novo Nordisk A/S Oral Obesity Therapies Product Offered
Table 88. Novo Nordisk A/S Oral Obesity Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. Novo Nordisk A/S Main Business
Table 90. Novo Nordisk A/S Latest Developments
Table 91. Pfizer Inc. Details, Company Type, Oral Obesity Therapies Area Served and Its Competitors
Table 92. Pfizer Inc. Oral Obesity Therapies Product Offered
Table 93. Pfizer Inc. Oral Obesity Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. Pfizer Inc. Main Business
Table 95. Pfizer Inc. Latest Developments
Table 96. Arena Pharmaceuticals, Inc. Details, Company Type, Oral Obesity Therapies Area Served and Its Competitors
Table 97. Arena Pharmaceuticals, Inc. Oral Obesity Therapies Product Offered
Table 98. Arena Pharmaceuticals, Inc. Oral Obesity Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. Arena Pharmaceuticals, Inc. Main Business
Table 100. Arena Pharmaceuticals, Inc. Latest Developments
Table 101. Rhythm Pharmaceuticals, Inc. Details, Company Type, Oral Obesity Therapies Area Served and Its Competitors
Table 102. Rhythm Pharmaceuticals, Inc. Oral Obesity Therapies Product Offered
Table 103. Rhythm Pharmaceuticals, Inc. Oral Obesity Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 104. Rhythm Pharmaceuticals, Inc. Main Business
Table 105. Rhythm Pharmaceuticals, Inc. Latest Developments
Table 106. Gelesis Details, Company Type, Oral Obesity Therapies Area Served and Its Competitors
Table 107. Gelesis Oral Obesity Therapies Product Offered
Table 108. Gelesis Oral Obesity Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 109. Gelesis Main Business
Table 110. Gelesis Latest Developments
Table 1. Oral Obesity Therapies Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Oral Obesity Therapies Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Lipase Inhibitors
Table 4. Major Players of Sympathomimetic Appetite Suppressants
Table 5. Major Players of Oral GLP-1 Agonists
Table 6. Major Players of Other
Table 7. Oral Obesity Therapies Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Oral Obesity Therapies Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Oral Obesity Therapies Market Size Market Share by Type (2021-2026)
Table 10. Major Players of Small Molecules
Table 11. Major Players of Peptide Oral
Table 12. Major Players of Combination Drugs
Table 13. Major Players of Other
Table 14. Oral Obesity Therapies Market Size CAGR by Drug Type (2021 VS 2025 VS 2032) & ($ millions)
Table 15. Global Oral Obesity Therapies Market Size by Drug Type (2021-2026) & ($ millions)
Table 16. Global Oral Obesity Therapies Market Size Market Share by Drug Type (2021-2026)
Table 17. Major Players of BMI ?30 Primary Obesity
Table 18. Major Players of Overweight + Metabolic Comorbidities
Table 19. Major Players of Short-term Weight Reduction
Table 20. Major Players of Weight Maintenance
Table 21. Oral Obesity Therapies Market Size CAGR by Patient Indication (2021 VS 2025 VS 2032) & ($ millions)
Table 22. Global Oral Obesity Therapies Market Size by Patient Indication (2021-2026) & ($ millions)
Table 23. Global Oral Obesity Therapies Market Size Market Share by Patient Indication (2021-2026)
Table 24. Oral Obesity Therapies Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 25. Global Oral Obesity Therapies Market Size by Application (2021-2026) & ($ millions)
Table 26. Global Oral Obesity Therapies Market Size Market Share by Application (2021-2026)
Table 27. Global Oral Obesity Therapies Revenue by Player (2021-2026) & ($ millions)
Table 28. Global Oral Obesity Therapies Revenue Market Share by Player (2021-2026)
Table 29. Oral Obesity Therapies Key Players Head office and Products Offered
Table 30. Oral Obesity Therapies Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 31. New Products and Potential Entrants
Table 32. Mergers & Acquisitions, Expansion
Table 33. Global Oral Obesity Therapies Market Size by Region (2021-2026) & ($ millions)
Table 34. Global Oral Obesity Therapies Market Size Market Share by Region (2021-2026)
Table 35. Global Oral Obesity Therapies Revenue by Country/Region (2021-2026) & ($ millions)
Table 36. Global Oral Obesity Therapies Revenue Market Share by Country/Region (2021-2026)
Table 37. Americas Oral Obesity Therapies Market Size by Country (2021-2026) & ($ millions)
Table 38. Americas Oral Obesity Therapies Market Size Market Share by Country (2021-2026)
Table 39. Americas Oral Obesity Therapies Market Size by Type (2021-2026) & ($ millions)
Table 40. Americas Oral Obesity Therapies Market Size Market Share by Type (2021-2026)
Table 41. Americas Oral Obesity Therapies Market Size by Application (2021-2026) & ($ millions)
Table 42. Americas Oral Obesity Therapies Market Size Market Share by Application (2021-2026)
Table 43. APAC Oral Obesity Therapies Market Size by Region (2021-2026) & ($ millions)
Table 44. APAC Oral Obesity Therapies Market Size Market Share by Region (2021-2026)
Table 45. APAC Oral Obesity Therapies Market Size by Type (2021-2026) & ($ millions)
Table 46. APAC Oral Obesity Therapies Market Size by Application (2021-2026) & ($ millions)
Table 47. Europe Oral Obesity Therapies Market Size by Country (2021-2026) & ($ millions)
Table 48. Europe Oral Obesity Therapies Market Size Market Share by Country (2021-2026)
Table 49. Europe Oral Obesity Therapies Market Size by Type (2021-2026) & ($ millions)
Table 50. Europe Oral Obesity Therapies Market Size by Application (2021-2026) & ($ millions)
Table 51. Middle East & Africa Oral Obesity Therapies Market Size by Region (2021-2026) & ($ millions)
Table 52. Middle East & Africa Oral Obesity Therapies Market Size by Type (2021-2026) & ($ millions)
Table 53. Middle East & Africa Oral Obesity Therapies Market Size by Application (2021-2026) & ($ millions)
Table 54. Key Market Drivers & Growth Opportunities of Oral Obesity Therapies
Table 55. Key Market Challenges & Risks of Oral Obesity Therapies
Table 56. Key Industry Trends of Oral Obesity Therapies
Table 57. Global Oral Obesity Therapies Market Size Forecast by Region (2027-2032) & ($ millions)
Table 58. Global Oral Obesity Therapies Market Size Market Share Forecast by Region (2027-2032)
Table 59. Global Oral Obesity Therapies Market Size Forecast by Type (2027-2032) & ($ millions)
Table 60. Global Oral Obesity Therapies Market Size Forecast by Application (2027-2032) & ($ millions)
Table 61. Currax Pharmaceuticals, LLC Details, Company Type, Oral Obesity Therapies Area Served and Its Competitors
Table 62. Currax Pharmaceuticals, LLC Oral Obesity Therapies Product Offered
Table 63. Currax Pharmaceuticals, LLC Oral Obesity Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Currax Pharmaceuticals, LLC Main Business
Table 65. Currax Pharmaceuticals, LLC Latest Developments
Table 66. Vivus, Inc. Details, Company Type, Oral Obesity Therapies Area Served and Its Competitors
Table 67. Vivus, Inc. Oral Obesity Therapies Product Offered
Table 68. Vivus, Inc. Oral Obesity Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Vivus, Inc. Main Business
Table 70. Vivus, Inc. Latest Developments
Table 71. Roche Holding AG Details, Company Type, Oral Obesity Therapies Area Served and Its Competitors
Table 72. Roche Holding AG Oral Obesity Therapies Product Offered
Table 73. Roche Holding AG Oral Obesity Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Roche Holding AG Main Business
Table 75. Roche Holding AG Latest Developments
Table 76. Teva Pharmaceutical Industries Ltd. Details, Company Type, Oral Obesity Therapies Area Served and Its Competitors
Table 77. Teva Pharmaceutical Industries Ltd. Oral Obesity Therapies Product Offered
Table 78. Teva Pharmaceutical Industries Ltd. Oral Obesity Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Teva Pharmaceutical Industries Ltd. Main Business
Table 80. Teva Pharmaceutical Industries Ltd. Latest Developments
Table 81. Sun Pharmaceutical Industries Ltd. Details, Company Type, Oral Obesity Therapies Area Served and Its Competitors
Table 82. Sun Pharmaceutical Industries Ltd. Oral Obesity Therapies Product Offered
Table 83. Sun Pharmaceutical Industries Ltd. Oral Obesity Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Sun Pharmaceutical Industries Ltd. Main Business
Table 85. Sun Pharmaceutical Industries Ltd. Latest Developments
Table 86. Novo Nordisk A/S Details, Company Type, Oral Obesity Therapies Area Served and Its Competitors
Table 87. Novo Nordisk A/S Oral Obesity Therapies Product Offered
Table 88. Novo Nordisk A/S Oral Obesity Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. Novo Nordisk A/S Main Business
Table 90. Novo Nordisk A/S Latest Developments
Table 91. Pfizer Inc. Details, Company Type, Oral Obesity Therapies Area Served and Its Competitors
Table 92. Pfizer Inc. Oral Obesity Therapies Product Offered
Table 93. Pfizer Inc. Oral Obesity Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. Pfizer Inc. Main Business
Table 95. Pfizer Inc. Latest Developments
Table 96. Arena Pharmaceuticals, Inc. Details, Company Type, Oral Obesity Therapies Area Served and Its Competitors
Table 97. Arena Pharmaceuticals, Inc. Oral Obesity Therapies Product Offered
Table 98. Arena Pharmaceuticals, Inc. Oral Obesity Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. Arena Pharmaceuticals, Inc. Main Business
Table 100. Arena Pharmaceuticals, Inc. Latest Developments
Table 101. Rhythm Pharmaceuticals, Inc. Details, Company Type, Oral Obesity Therapies Area Served and Its Competitors
Table 102. Rhythm Pharmaceuticals, Inc. Oral Obesity Therapies Product Offered
Table 103. Rhythm Pharmaceuticals, Inc. Oral Obesity Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 104. Rhythm Pharmaceuticals, Inc. Main Business
Table 105. Rhythm Pharmaceuticals, Inc. Latest Developments
Table 106. Gelesis Details, Company Type, Oral Obesity Therapies Area Served and Its Competitors
Table 107. Gelesis Oral Obesity Therapies Product Offered
Table 108. Gelesis Oral Obesity Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 109. Gelesis Main Business
Table 110. Gelesis Latest Developments
LIST OF FIGURES
Figure 1. Oral Obesity Therapies Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Oral Obesity Therapies Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Oral Obesity Therapies Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Oral Obesity Therapies Sales Market Share by Country/Region (2025)
Figure 8. Oral Obesity Therapies Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Oral Obesity Therapies Market Size Market Share by Type in 2025
Figure 10. Global Oral Obesity Therapies Market Size Market Share by Drug Type in 2025
Figure 11. Global Oral Obesity Therapies Market Size Market Share by Patient Indication in 2025
Figure 12. Oral Obesity Therapies in Hospitals
Figure 13. Global Oral Obesity Therapies Market: Hospitals (2021-2026) & ($ millions)
Figure 14. Oral Obesity Therapies in Retail Pharmacies
Figure 15. Global Oral Obesity Therapies Market: Retail Pharmacies (2021-2026) & ($ millions)
Figure 16. Oral Obesity Therapies in Other
Figure 17. Global Oral Obesity Therapies Market: Other (2021-2026) & ($ millions)
Figure 18. Global Oral Obesity Therapies Market Size Market Share by Application in 2025
Figure 19. Global Oral Obesity Therapies Revenue Market Share by Player in 2025
Figure 20. Global Oral Obesity Therapies Market Size Market Share by Region (2021-2026)
Figure 21. Americas Oral Obesity Therapies Market Size 2021-2026 ($ millions)
Figure 22. APAC Oral Obesity Therapies Market Size 2021-2026 ($ millions)
Figure 23. Europe Oral Obesity Therapies Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Oral Obesity Therapies Market Size 2021-2026 ($ millions)
Figure 25. Americas Oral Obesity Therapies Value Market Share by Country in 2025
Figure 26. United States Oral Obesity Therapies Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Oral Obesity Therapies Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Oral Obesity Therapies Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Oral Obesity Therapies Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Oral Obesity Therapies Market Size Market Share by Region in 2025
Figure 31. APAC Oral Obesity Therapies Market Size Market Share by Type (2021-2026)
Figure 32. APAC Oral Obesity Therapies Market Size Market Share by Application (2021-2026)
Figure 33. China Oral Obesity Therapies Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Oral Obesity Therapies Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Oral Obesity Therapies Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Oral Obesity Therapies Market Size Growth 2021-2026 ($ millions)
Figure 37. India Oral Obesity Therapies Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Oral Obesity Therapies Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Oral Obesity Therapies Market Size Market Share by Country in 2025
Figure 40. Europe Oral Obesity Therapies Market Size Market Share by Type (2021-2026)
Figure 41. Europe Oral Obesity Therapies Market Size Market Share by Application (2021-2026)
Figure 42. Germany Oral Obesity Therapies Market Size Growth 2021-2026 ($ millions)
Figure 43. France Oral Obesity Therapies Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Oral Obesity Therapies Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Oral Obesity Therapies Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Oral Obesity Therapies Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Oral Obesity Therapies Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Oral Obesity Therapies Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Oral Obesity Therapies Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Oral Obesity Therapies Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Oral Obesity Therapies Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Oral Obesity Therapies Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Oral Obesity Therapies Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Oral Obesity Therapies Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Oral Obesity Therapies Market Size 2027-2032 ($ millions)
Figure 56. APAC Oral Obesity Therapies Market Size 2027-2032 ($ millions)
Figure 57. Europe Oral Obesity Therapies Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Oral Obesity Therapies Market Size 2027-2032 ($ millions)
Figure 59. United States Oral Obesity Therapies Market Size 2027-2032 ($ millions)
Figure 60. Canada Oral Obesity Therapies Market Size 2027-2032 ($ millions)
Figure 61. Mexico Oral Obesity Therapies Market Size 2027-2032 ($ millions)
Figure 62. Brazil Oral Obesity Therapies Market Size 2027-2032 ($ millions)
Figure 63. China Oral Obesity Therapies Market Size 2027-2032 ($ millions)
Figure 64. Japan Oral Obesity Therapies Market Size 2027-2032 ($ millions)
Figure 65. Korea Oral Obesity Therapies Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Oral Obesity Therapies Market Size 2027-2032 ($ millions)
Figure 67. India Oral Obesity Therapies Market Size 2027-2032 ($ millions)
Figure 68. Australia Oral Obesity Therapies Market Size 2027-2032 ($ millions)
Figure 69. Germany Oral Obesity Therapies Market Size 2027-2032 ($ millions)
Figure 70. France Oral Obesity Therapies Market Size 2027-2032 ($ millions)
Figure 71. UK Oral Obesity Therapies Market Size 2027-2032 ($ millions)
Figure 72. Italy Oral Obesity Therapies Market Size 2027-2032 ($ millions)
Figure 73. Russia Oral Obesity Therapies Market Size 2027-2032 ($ millions)
Figure 74. Egypt Oral Obesity Therapies Market Size 2027-2032 ($ millions)
Figure 75. South Africa Oral Obesity Therapies Market Size 2027-2032 ($ millions)
Figure 76. Israel Oral Obesity Therapies Market Size 2027-2032 ($ millions)
Figure 77. Turkey Oral Obesity Therapies Market Size 2027-2032 ($ millions)
Figure 78. Global Oral Obesity Therapies Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Oral Obesity Therapies Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Oral Obesity Therapies Market Size 2027-2032 ($ millions)
Figure 1. Oral Obesity Therapies Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Oral Obesity Therapies Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Oral Obesity Therapies Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Oral Obesity Therapies Sales Market Share by Country/Region (2025)
Figure 8. Oral Obesity Therapies Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Oral Obesity Therapies Market Size Market Share by Type in 2025
Figure 10. Global Oral Obesity Therapies Market Size Market Share by Drug Type in 2025
Figure 11. Global Oral Obesity Therapies Market Size Market Share by Patient Indication in 2025
Figure 12. Oral Obesity Therapies in Hospitals
Figure 13. Global Oral Obesity Therapies Market: Hospitals (2021-2026) & ($ millions)
Figure 14. Oral Obesity Therapies in Retail Pharmacies
Figure 15. Global Oral Obesity Therapies Market: Retail Pharmacies (2021-2026) & ($ millions)
Figure 16. Oral Obesity Therapies in Other
Figure 17. Global Oral Obesity Therapies Market: Other (2021-2026) & ($ millions)
Figure 18. Global Oral Obesity Therapies Market Size Market Share by Application in 2025
Figure 19. Global Oral Obesity Therapies Revenue Market Share by Player in 2025
Figure 20. Global Oral Obesity Therapies Market Size Market Share by Region (2021-2026)
Figure 21. Americas Oral Obesity Therapies Market Size 2021-2026 ($ millions)
Figure 22. APAC Oral Obesity Therapies Market Size 2021-2026 ($ millions)
Figure 23. Europe Oral Obesity Therapies Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Oral Obesity Therapies Market Size 2021-2026 ($ millions)
Figure 25. Americas Oral Obesity Therapies Value Market Share by Country in 2025
Figure 26. United States Oral Obesity Therapies Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Oral Obesity Therapies Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Oral Obesity Therapies Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Oral Obesity Therapies Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Oral Obesity Therapies Market Size Market Share by Region in 2025
Figure 31. APAC Oral Obesity Therapies Market Size Market Share by Type (2021-2026)
Figure 32. APAC Oral Obesity Therapies Market Size Market Share by Application (2021-2026)
Figure 33. China Oral Obesity Therapies Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Oral Obesity Therapies Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Oral Obesity Therapies Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Oral Obesity Therapies Market Size Growth 2021-2026 ($ millions)
Figure 37. India Oral Obesity Therapies Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Oral Obesity Therapies Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Oral Obesity Therapies Market Size Market Share by Country in 2025
Figure 40. Europe Oral Obesity Therapies Market Size Market Share by Type (2021-2026)
Figure 41. Europe Oral Obesity Therapies Market Size Market Share by Application (2021-2026)
Figure 42. Germany Oral Obesity Therapies Market Size Growth 2021-2026 ($ millions)
Figure 43. France Oral Obesity Therapies Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Oral Obesity Therapies Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Oral Obesity Therapies Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Oral Obesity Therapies Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Oral Obesity Therapies Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Oral Obesity Therapies Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Oral Obesity Therapies Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Oral Obesity Therapies Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Oral Obesity Therapies Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Oral Obesity Therapies Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Oral Obesity Therapies Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Oral Obesity Therapies Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Oral Obesity Therapies Market Size 2027-2032 ($ millions)
Figure 56. APAC Oral Obesity Therapies Market Size 2027-2032 ($ millions)
Figure 57. Europe Oral Obesity Therapies Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Oral Obesity Therapies Market Size 2027-2032 ($ millions)
Figure 59. United States Oral Obesity Therapies Market Size 2027-2032 ($ millions)
Figure 60. Canada Oral Obesity Therapies Market Size 2027-2032 ($ millions)
Figure 61. Mexico Oral Obesity Therapies Market Size 2027-2032 ($ millions)
Figure 62. Brazil Oral Obesity Therapies Market Size 2027-2032 ($ millions)
Figure 63. China Oral Obesity Therapies Market Size 2027-2032 ($ millions)
Figure 64. Japan Oral Obesity Therapies Market Size 2027-2032 ($ millions)
Figure 65. Korea Oral Obesity Therapies Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Oral Obesity Therapies Market Size 2027-2032 ($ millions)
Figure 67. India Oral Obesity Therapies Market Size 2027-2032 ($ millions)
Figure 68. Australia Oral Obesity Therapies Market Size 2027-2032 ($ millions)
Figure 69. Germany Oral Obesity Therapies Market Size 2027-2032 ($ millions)
Figure 70. France Oral Obesity Therapies Market Size 2027-2032 ($ millions)
Figure 71. UK Oral Obesity Therapies Market Size 2027-2032 ($ millions)
Figure 72. Italy Oral Obesity Therapies Market Size 2027-2032 ($ millions)
Figure 73. Russia Oral Obesity Therapies Market Size 2027-2032 ($ millions)
Figure 74. Egypt Oral Obesity Therapies Market Size 2027-2032 ($ millions)
Figure 75. South Africa Oral Obesity Therapies Market Size 2027-2032 ($ millions)
Figure 76. Israel Oral Obesity Therapies Market Size 2027-2032 ($ millions)
Figure 77. Turkey Oral Obesity Therapies Market Size 2027-2032 ($ millions)
Figure 78. Global Oral Obesity Therapies Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Oral Obesity Therapies Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Oral Obesity Therapies Market Size 2027-2032 ($ millions)
